U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT07568756) titled 'Utilization of Flotufolastat 18F PET for Post-Focal Therapy Prostate Cancer Evaluation' on April 28.
Brief Summary: This is a phase II single arm, open-label clinical trial determining diagnostic accuracy of Flotufolastat F18 PET in subjects with prostate adenocarcinoma. These are subjects who have not previously received treatment for prostate cancer.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Prostate Adenocarcinoma
Prostate Cancer
Intervention:
DIAGNOSTIC_TEST: Flotufolastat F18 PET
Flotufolastat F18 PET
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of California, Irvine
Information pro...